New progress in pediatric allergic rhinitis

Miao Cheng1, Qianqian Dai2, Zhi Liu3

  • 1Department of Ophthalmology and Otolaryngology, Jingmen Centra Hospital, Jingmen Central Hospital Affiliated to Jingchu University of Technology, Jingmen, Hubei, China.

Frontiers in Immunology
|October 1, 2024
PubMed

Insights

Allergic rhinitis (AR) in children is rising, influenced by genetics and environment. Personalized treatments like immunotherapy improve quality of life.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Genetics

Background:

  • Increasing prevalence of allergic rhinitis (AR) in children globally.
  • AR onset linked to genetic predisposition, environmental factors, and allergen exposure.
  • Growing need for advanced diagnostic and management strategies for pediatric AR.

Purpose of the Study:

  • To review recent research on the etiology, diagnosis, and treatment of pediatric allergic rhinitis.
  • To highlight personalized approaches and health management strategies for children with AR.
  • To provide insights for improving diagnosis, treatment, and quality of life for affected children.

Main Methods:

  • Comprehensive literature review of recent studies on pediatric allergic rhinitis.
  • Analysis of etiological factors, diagnostic classifications, and therapeutic interventions.
  • Examination of personalized treatment modalities and health management frameworks.

Main Results:

  • Identified key genetic and environmental factors contributing to pediatric AR.
  • Reviewed various diagnostic methods aiding in AR identification.
  • Highlighted the growing efficacy of personalized treatments including environmental control and allergen-specific immunotherapy.

Conclusions:

  • Personalized diagnosis and treatment are crucial for managing pediatric allergic rhinitis effectively.
  • Integration of environmental control and allergen-specific immunotherapy can significantly improve patient outcomes.
  • Enhanced health management strategies are vital for improving symptoms and the overall quality of life in children with AR.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
183
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358